Edward J Dulac Iii is EVP, Chief Financial Officer of Intellia Therapeutics, Inc.. Currently has a direct ownership of 113,524 shares of NTLA, which is worth approximately $916,138. The most recent transaction as insider was on Mar 01, 2025, when has been sold 47,200 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 114K
71.17% 3M change
n/a 12M change
Total Value Held $916,138

Edward J Dulac III Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2025
BUY
Grant, award, or other acquisition
-
47,200 Added 29.37%
113,524 Common Stock
Jul 22 2024
BUY
Grant, award, or other acquisition
-
66,324 Added 50.0%
66,324 Common Stock

Also insider at

FATE
FATE THERAPEUTICS INC Healthcare
EJD

Edward J Dulac Iii

EVP, Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on NTLA

Follow Intellia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

News

Receive news related to Intellia Therapeutics, Inc.

Track Activities on NTLA